The spin-out from Queen's University Belfast secured the cash injection from NetScientific and Qubis.

ProAxsis, a life sciences firm spun out from Queen’s University’s School of Pharmacy in August 2013, has secured its first major investment courtesy of NetScientific and Qubis. The amount, while undisclosed, will help the company create up to eight jobs over the next three years. ProAxsis has developed a range of medical diagnostic test kits to enable routine monitoring of patients with chronic respiratory conditions such as cystic fibrosis, either in a hospital or at home. The company previously won the 2013 NISP CONNECT 25K award, worth £10,000 ($16,800) and run by the European Sustainable Competitiveness Programme for Northern Ireland, a part of the European Regional Development Fund. Qubis is the university’s technology transfer office, established in 1984, with a portfolio focusing on digital technologies, green technologies, life sciences and engineering. NetScientific is a healthcare medical technology company that identifies, develops and commercialises research and technologies originating from universities, teaching hospitals and research institutes worldwide, with a particular focus on UK and US institutions. Lorraine Martin, co-founder of ProAxsis, said: “In NetScientific, we have found the ideal partner, affording us the opportunity to collaborate with a global network for commercialisation and technical product development.”

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?